The Form 4 filing was submitted to the SEC on November 16, 2026. The reported sale took place on the same date. Form 4 reports changes in an insider’s share ownership.
Thomas A. Devasia serves as executive vice president and chief marketing and innovation officer at Concentra Group Holdings Parent, Inc. The company, which trades as CON, is in the healthcare sector’s medical care facilities industry.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 18,194 |
| Price | $42.92 |
| Total Transaction Value | $780,977.45 |
| Insider | |
| Ticker Symbol | CON |
| Company | Concentra Group Holdings Parent, Inc. |
| Insider Name | Devasia Thomas A. |
| Insider Title | Executive Vice President, Chief Marketing and Innovation Officer |
| Sector - Industry | Healthcare - Medical Care Facilities |
| Holdings | |
| Total Shares Owned After Transaction | 125,320 |
| Position Size Change | 12.68% |
| Filing | |
| Filing Date | 2026-11-16 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, listed with transaction code S. The record covers one transaction by Thomas A. Devasia.
What was the average price of the transaction?
The reported average price was $42.925 per share. It appears as $42.92 in the transaction details above, which show the price to two decimal places.
How did this transaction affect the insider's holdings?
Thomas A. Devasia sold 18,194 shares and reported 125,320 shares owned after the sale. The shares sold made up 12.68% of his reported holdings before the trade.
What's the total transaction value?
The single sale had a total value of $780,977.45. That is the reported value of all 18,194 shares sold.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for this sale. Filing footnote text was not available, so any added terms or explanations in those notes remain unknown.
For research purposes only; not investment advice.